R, M., Y, B., H, L., T, L., S, I., C, A., . . . NA, C. (2023). Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma. Annals of surgical oncology, 30(8), 5027. https://doi.org/10.1245/s10434-023-13533-0
Chicago Style (17th ed.) CitationR, Macfie, et al. "Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma." Annals of Surgical Oncology 30, no. 8 (2023): 5027. https://doi.org/10.1245/s10434-023-13533-0.
MLA (9th ed.) CitationR, Macfie, et al. "Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma." Annals of Surgical Oncology, vol. 30, no. 8, 2023, p. 5027, https://doi.org/10.1245/s10434-023-13533-0.